Brief: Hikma Aspires To Spend 5%-6% Of Revenue On Research And Development
22/09/2026 12:35
BRIEF-Hikma Aspires To Spend 5%-6% Of Revenue On Research And Development Sept 22 (Reuters) - Hikma Pharmaceuticals PLC HIK.L:
HIKMA - ASPIRES TO SPEND 5%-6% OF REVENUE ON RESEARCH AND DEVELOPMENT
Source text: ID:nRSV8163Va
Further company coverage: HIK.L